Chunghwa Chemical Synthesis & Biotech Co., Ltd. logo

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

TWSE:1762.TW

Overview | Financials
Company Name Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Symbol 1762.TW
Currency TWD
Price 53.3
Market Cap 4,133,948,000
Dividend Yield 2.82%
52-week-range 43.6 - 81.5
Industry Biotechnology
Sector Healthcare
CEO Mr. Chung-Hsin Huang
Website https://www.ccsb.com.tw

An error occurred while fetching data.

About Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products,

Related Stocks

Sinphar Pharmaceutical Co.,Ltd. logo

Sinphar Pharmaceutical Co.,Ltd.

1734.TW

37.65 TWD

Medtecs International Corporation Limited logo

Medtecs International Corporation Limited

9103.TW

8.02 TWD

Bionime Corporation logo

Bionime Corporation

4737.TW

69 TWD

PhytoHealth Corporation logo

PhytoHealth Corporation

4108.TW

20.05 TWD

Nang Kuang Pharmaceutical Co., Ltd. logo

Nang Kuang Pharmaceutical Co., Ltd.

1752.TW

48.1 TWD

Formosa Laboratories, Inc. logo

Formosa Laboratories, Inc.

4746.TW

103 TWD

CHC Healthcare Group logo

CHC Healthcare Group

4164.TW

49.3 TWD

Maxigen Biotech Inc. logo

Maxigen Biotech Inc.

1783.TW

44.95 TWD

SciVision Biotech Inc. logo

SciVision Biotech Inc.

1786.TW

116.5 TWD

Apex Medical Corp. logo

Apex Medical Corp.

4106.TW

28.7 TWD

Financials

Numbers are in millions USD

Numbers are in millions USD